Controlling the size of nanoclusters: First step in making new...(er molecules. Exploring larger and more ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Controlling the size of nanoclusters: First step in making new catalysts
Date:7/9/2008
er molecules. Exploring larger and more reactive nanoclusters will be the next step.
"This was a study to test the capabilities of the newly built instrument," White said. "Now we can do further studies with different nanoclusters to find those that are most reactive and therefore best suited as models for making the most efficient nanocatalysts."
'/>"/>
| Contact: Diane Greenberg greenb@bnl.gov 631-344-2347 DOE/Brookhaven National Laboratory Source:Eurekalert |
Related biology technology :
1. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
2. Gladstone scientists identify role of tiny RNAs in controlling stem cell fate
3. Presentation of North Americas First Certificate for BS 25999, the New Standard for Business Continuity
4. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
5. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
6. Edmonton to be site of worlds first industrial scale municipal waste-to-ethanol facility
7. ActivBiotics Assignee Issues First Distribution of Cash to Creditors
8. HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
9. Start of First Fingertip Payment Pilot in the Netherlands
10. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
11. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
Post Your Comments:
Breaking Biology Technology:Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2
[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea[0] Waters Ships First Units of SYNAPT G2 Mass Spectrometer[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas[0] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
Other Biology Technology:Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 2Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 3Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 4Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 5Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 6Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 7Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 8Real-Time Multiplex PCR from Genomic DNA Using the iCycler iQ Detection System 9Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 2Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 3Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 4Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 5Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 6Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 7Genomic DNA Isolation Protocol for 40 l Avian Whole Blood 2
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 2Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4Savannah City Leaders Launch Medicare Diabetes Screening Project 52264 1Savannah City Leaders Launch Medicare Diabetes Screening Project 52264 2Savannah City Leaders Launch Medicare Diabetes Screening Project 52264 3IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 1IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 2Healthplace America Names Todd Roscoe to New Position of Chief Managed Care Officer 52260 1Healthplace America Names Todd Roscoe to New Position of Chief Managed Care Officer 52260 2Healthplace America Names Todd Roscoe to New Position of Chief Managed Care Officer 52260 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |